Melodia Therapeutics is a startup based in Switzerland.
Based in Switzerland, Melodia Therapeutics is a startup.
Melodia Therapeutics is a Basel-based biotechnology company developing therapies for neutrophil-driven diseases. The company is advancing a cathepsin-C inhibitor program and has entered licensing collaborations to develop these therapeutic candidates.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.